FDA Expands Telmisartan Indications

WASHINGTON (MedPage Today) The FDA has expanded the indication for the antihypertension drug telmisartan (Micardis), making it the first angiotensin receptor blocker (ARB) approved for primary prevention in high-risk patients unable to take an ACE inhibitor.

source : www.medpagetoday.com

Related News:

• SSRI and Tamoxifen Increase Mortality Risk (CME/CE)
• AAPM: Capsaicin Patch Unaffected by Anesthestics (CME/CE)
• AAPM: Spine Stimulation Leads to Durable Pain Relief (CME/CE)
• AAPM: Botox May Relieve Postherpetic Neuralgia (CME/CE)
• HRT Linked to Asthma Risk (CME/CE)
• AM: Facet Graft Quells Refractory Back Pain (CME/CE)
• AM: Spine Stimulation Leads to Durable Pain Relief (CME/CE)
• AM: Botox May Relieve Postherpetic Neuralgia (CME/CE)
• AM: Drug for Fibromyalgia Boosts Multiple Outcomes (CME/CE)
• AM: Help for Pain and Mood in Fibromyalgia (CME/CE)

Details :
Submited at Monday, October 19th, 2009 at 6:02 pm on Cardiology by admin
Comment RSS 2.0 - leave a comment - trackback